FDA Warns Hospira Over Issues At Costa Rican Plant

Law360, New York (August 28, 2012, 7:26 PM EDT) -- Hospira Inc. disclosed on Tuesday that it has received a warning letter from the U.S. Food and Drug Administration regarding quality issues uncovered during an inspection of a Costa Rican facility at which most of the company's infusion devices and sets are manufactured.

In a report filed Tuesday with the U.S. Securities and Exchange Commission, the device maker said it had received a letter on Aug. 23 citing numerous issues at its La Aurora de Heredia, Costa Rica, device manufacturing facility, though it noted that the...
To view the full article, register now.